• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现具有增强抗病毒性能的泰诺福韦的修饰酰胺(前药)前药。

Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties.

机构信息

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 160 00 Prague 6, Czech Republic.

Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43 Prague 2, Czech Republic.

出版信息

J Med Chem. 2021 Nov 25;64(22):16425-16449. doi: 10.1021/acs.jmedchem.1c01444. Epub 2021 Oct 29.

DOI:10.1021/acs.jmedchem.1c01444
PMID:34713696
Abstract

This study describes the discovery of novel prodrugs bearing tyrosine derivatives instead of the phenol moiety present in FDA-approved tenofovir alafenamide fumarate (TAF). The synthesis was optimized to afford diastereomeric mixtures of novel prodrugs in one pot (yields up to 86%), and the epimers were resolved using a chiral HPLC column into fast-eluting and slow-eluting epimers. In human lymphocytes, the most efficient tyrosine-based prodrug reached a single-digit picomolar EC value against HIV-1 and nearly 300-fold higher selectivity index (SI) compared to TAF. In human hepatocytes, the most efficient prodrugs exhibited subnanomolar EC values for HBV and up to 26-fold higher SI compared to TAF. Metabolic studies demonstrated markedly higher cellular uptake of the prodrugs and substantially higher levels of released tenofovir inside the cells compared to TAF. These promising results provide a strong foundation for further evaluation of the reported prodrugs and their potential utility in the development of highly potent antivirals.

摘要

本研究描述了新型前药的发现,这些前药带有酪氨酸衍生物,而不是已获 FDA 批准的替诺福韦艾拉酚胺富马酸盐(TAF)中的酚部分。合成经过优化,一锅法提供了新型前药的非对映异构体混合物(产率高达 86%),并使用手性 HPLC 柱将差向异构体拆分成为快速洗脱和缓慢洗脱的差向异构体。在人淋巴细胞中,最有效的酪氨酸基前药对 HIV-1 的 EC 值达到了个位数皮摩尔,与 TAF 相比,选择性指数(SI)高近 300 倍。在人肝细胞中,最有效的前药对 HBV 的 EC 值达到了亚纳摩尔,与 TAF 相比,SI 高 26 倍。代谢研究表明,与 TAF 相比,前药的细胞摄取率明显更高,细胞内释放的替诺福韦水平也显著更高。这些有前景的结果为进一步评估所报道的前药及其在开发高效抗病毒药物方面的潜在用途提供了坚实的基础。

相似文献

1
Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties.发现具有增强抗病毒性能的泰诺福韦的修饰酰胺(前药)前药。
J Med Chem. 2021 Nov 25;64(22):16425-16449. doi: 10.1021/acs.jmedchem.1c01444. Epub 2021 Oct 29.
2
Next-Generation Reduction Sensitive Lipid Conjugates of Tenofovir: Antiviral Activity and Mechanism of Release.下一代替诺福韦还原敏感脂质共轭物:抗病毒活性及释放机制
J Med Chem. 2016 Nov 23;59(22):10244-10252. doi: 10.1021/acs.jmedchem.6b01292. Epub 2016 Nov 2.
3
Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.2-氨基-6-氨基甲酰基嘌呤二氧戊环核苷衍生物及其磷酰胺酯前药的合成与抗病毒评价
Bioorg Med Chem. 2014 Dec 1;22(23):6665-6671. doi: 10.1016/j.bmc.2014.10.003. Epub 2014 Oct 13.
4
Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.脱氧苏糖核苷膦酸酯的酰胺化前药作为HIV和HBV复制的双重抑制剂
J Med Chem. 2016 Oct 27;59(20):9513-9531. doi: 10.1021/acs.jmedchem.6b01260. Epub 2016 Oct 17.
5
Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro.HIV-1对替诺福韦艾拉酚胺的体外耐药性特征分析
Antimicrob Agents Chemother. 2015 Oct;59(10):5917-24. doi: 10.1128/AAC.01151-15. Epub 2015 Jul 6.
6
Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.替诺福韦的还原敏感脂质缀合物:合成、稳定性及抗病毒活性
J Med Chem. 2016 Aug 11;59(15):7097-110. doi: 10.1021/acs.jmedchem.6b00428. Epub 2016 Jul 22.
7
Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC-MS/MS method.采用灵敏的 LC-MS/MS 方法同时测定乙型肝炎感染肝细胞中的替诺福韦艾拉酚胺及其活性代谢物替诺福韦和替诺福韦二磷酸。
J Pharm Biomed Anal. 2017 Nov 30;146:147-153. doi: 10.1016/j.jpba.2017.08.028. Epub 2017 Aug 30.
8
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.具有抗病毒活性的氨基磷酸酯和膦酰氨基甲酸酯(前药)。
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618775243. doi: 10.1177/2040206618775243.
9
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V.替诺福韦艾拉酚胺对含胸苷类似物相关突变和 M184V 的 HIV-1 的抗病毒活性。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02557-19.
10
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro.替诺福韦艾拉酚胺对野生型HBV临床分离株显示出广泛的跨基因型活性,并在体外对耐药HBV分离株保持敏感性。
Antiviral Res. 2017 Mar;139:25-31. doi: 10.1016/j.antiviral.2016.12.012. Epub 2016 Dec 23.

引用本文的文献

1
Development of Prolinol Containing Inhibitors of Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design.脯氨醇类次黄嘌呤-鸟嘌呤-黄嘌呤磷酸核糖基转移酶抑制剂的开发:基于合理结构的药物设计。
J Med Chem. 2024 May 9;67(9):7158-7175. doi: 10.1021/acs.jmedchem.4c00021. Epub 2024 Apr 23.
2
The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors.前药在增强核苷逆转录酶抑制剂性质中的应用。
Viruses. 2023 Nov 9;15(11):2234. doi: 10.3390/v15112234.
3
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors.
强效 SARS-CoV-2 nsp14 甲基转移酶抑制剂的合理设计
ACS Omega. 2023 Jul 21;8(30):27410-27418. doi: 10.1021/acsomega.3c02815. eCollection 2023 Aug 1.
4
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.药物化学中的膦酸盐和膦酸盐前药:过去的成功与未来的前景
Front Chem. 2022 May 20;10:889737. doi: 10.3389/fchem.2022.889737. eCollection 2022.